ESTA vs. AVNS, ZJYL, INGN, ENOV, AKRO, MORF, AGTI, EYE, RCUS, and ANIP
Should you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include Avanos Medical (AVNS), Jin Medical International (ZJYL), Inogen (INGN), Enovis (ENOV), Akero Therapeutics (AKRO), Morphic (MORF), Agiliti (AGTI), National Vision (EYE), Arcus Biosciences (RCUS), and ANI Pharmaceuticals (ANIP). These companies are all part of the "medical" sector.
Establishment Labs (NASDAQ:ESTA) and Avanos Medical (NYSE:AVNS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, community ranking, media sentiment, profitability, institutional ownership, risk, dividends and earnings.
Avanos Medical has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.
Avanos Medical has a net margin of -9.15% compared to Establishment Labs' net margin of -47.53%. Avanos Medical's return on equity of 4.10% beat Establishment Labs' return on equity.
Establishment Labs has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500. Comparatively, Avanos Medical has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500.
Establishment Labs received 30 more outperform votes than Avanos Medical when rated by MarketBeat users. Likewise, 62.22% of users gave Establishment Labs an outperform vote while only 54.67% of users gave Avanos Medical an outperform vote.
72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 95.2% of Avanos Medical shares are held by institutional investors. 11.4% of Establishment Labs shares are held by insiders. Comparatively, 3.9% of Avanos Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Establishment Labs presently has a consensus target price of $55.00, suggesting a potential upside of 7.32%. Avanos Medical has a consensus target price of $31.00, suggesting a potential upside of 58.49%. Given Avanos Medical's higher possible upside, analysts clearly believe Avanos Medical is more favorable than Establishment Labs.
In the previous week, Avanos Medical had 11 more articles in the media than Establishment Labs. MarketBeat recorded 17 mentions for Avanos Medical and 6 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.22 beat Avanos Medical's score of 0.08 indicating that Establishment Labs is being referred to more favorably in the media.
Summary
Avanos Medical beats Establishment Labs on 10 of the 18 factors compared between the two stocks.
Get Establishment Labs News Delivered to You Automatically
Sign up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ESTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Establishment Labs Competitors List
Related Companies and Tools
